| Measuring lymphocyte proliferation, survival and differentiation using CFSE time-series data ED Hawkins, M Hommel, ML Turner, FL Battye, JF Markham, PD Hodgkin Nature protocols 2 (9), 2057-2067, 2007 | 296 | 2007 |
| Activation-induced B cell fates are selected by intracellular stochastic competition KR Duffy, CJ Wellard, JF Markham, JHS Zhou, R Holmberg, ED Hawkins, ... Science 335 (6066), 338-341, 2012 | 235 | 2012 |
| Attenuated vaccines can recombine to form virulent field viruses SW Lee, PF Markham, MJC Coppo, AR Legione, JF Markham, ... Science 337 (6091), 188-188, 2012 | 224 | 2012 |
| A single-cell pedigree analysis of alternative stochastic lymphocyte fates ED Hawkins, JF Markham, LP McGuinness, PD Hodgkin Proceedings of the National Academy of Sciences 106 (32), 13457-13462, 2009 | 168 | 2009 |
| Whole exome sequencing reveals activating JAK1 and STAT3 mutations in breast implant-associated anaplastic large cell lymphoma anaplastic large cell lymphoma P Blombery, ER Thompson, K Jones, GM Arnau, S Lade, JF Markham, ... Haematologica 101 (9), e387, 2016 | 159 | 2016 |
| Stretched cell cycle model for proliferating lymphocytes MR Dowling, A Kan, S Heinzel, JHS Zhou, JM Marchingo, CJ Wellard, ... Proceedings of the National Academy of Sciences 111 (17), 6377-6382, 2014 | 104 | 2014 |
| A lineage of diploid platelet-forming cells precedes polyploid megakaryocyte formation in the mouse embryo KS Potts, TJ Sargeant, JF Markham, W Shi, C Biben, EC Josefsson, ... Blood, The Journal of the American Society of Hematology 124 (17), 2725-2729, 2014 | 80 | 2014 |
| First complete genome sequence of infectious laryngotracheitis virus SW Lee, PF Markham, JF Markham, I Petermann, AH Noormohammadi, ... BMC genomics 12, 1-6, 2011 | 58 | 2011 |
| Phylogenetic and molecular epidemiological studies reveal evidence of multiple past recombination events between infectious laryngotracheitis viruses SW Lee, JM Devlin, JF Markham, AH Noormohammadi, GF Browning, ... PloS one 8 (2), e55121, 2013 | 56 | 2013 |
| Predicting expression: the complementary power of histone modification and transcription factor binding data DM Budden, DG Hurley, J Cursons, JF Markham, MJ Davis, EJ Crampin Epigenetics & chromatin 7, 1-12, 2014 | 45 | 2014 |
| Mathematical models and immune cell biology C Molina-París, G Lythe Springer Science & Business Media, 2011 | 44 | 2011 |
| Novel genomic findings in multiple myeloma identified through routine diagnostic sequencing GL Ryland, K Jones, M Chin, J Markham, E Aydogan, Y Kankanige, ... Journal of clinical pathology 71 (10), 895-899, 2018 | 37 | 2018 |
| Comparative analysis of the complete genome sequences of two Australian origin live attenuated vaccines of infectious laryngotracheitis virus SW Lee, JM Devlin, JF Markham, AH Noormohammadi, GF Browning, ... Vaccine 29 (52), 9583-9587, 2011 | 35 | 2011 |
| A minimum of two distinct heritable factors are required to explain correlation structures in proliferating lymphocytes JF Markham, CJ Wellard, ED Hawkins, KR Duffy, PD Hodgkin Journal of the Royal Society Interface 7 (48), 1049-1059, 2010 | 34 | 2010 |
| CNspector: a web-based tool for visualisation and clinical diagnosis of copy number variation from next generation sequencing JF Markham, S Yerneni, GL Ryland, HS Leong, A Fellowes, ... Scientific reports 9 (1), 6426, 2019 | 27 | 2019 |
| Automated and semi‐automated cell tracking: addressing portability challenges A Kan, R Chakravorty, J Bailey, C Leckie, J Markham, MR Dowling Journal of Microscopy 244 (2), 194-213, 2011 | 27 | 2011 |
| Stochastically timed competition between division and differentiation fates regulates the transition from B lymphoblast to plasma cell JHS Zhou, JF Markham, KR Duffy, PD Hodgkin Frontiers in immunology 9, 2053, 2018 | 26 | 2018 |
| Mutations in GTP binding protein Obg of Mycoplasma synoviae vaccine strain MS-H: implications in temperature-sensitivity phenotype MA Shahid, PF Markham, JF Markham, MS Marenda, ... PLoS One 8 (9), e73954, 2013 | 26 | 2013 |
| Single-cell sequencing demonstrates complex resistance landscape in CLL and MCL treated with BTK and BCL2 inhibitors ER Thompson, T Nguyen, Y Kankanige, JF Markham, MA Anderson, ... Blood advances 6 (2), 503-508, 2022 | 23 | 2022 |
| ASXL1 c.1934dup;p.Gly646Trpfs*12—a true somatic alteration requiring a new approach CK Yannakou, K Jones, M McBean, ER Thompson, GL Ryland, K Doig, ... Blood cancer journal 7 (12), 656, 2017 | 23 | 2017 |
Philip HodgkinProfessor of Immunology, Walter and Eliza Hall Institute在 wehi.edu.au 的电子邮件经过验证
